Don’t Develop It. Buy It! Tandem Buys AMF To Save Years Of R&D

To accelerate the development of its own patch-based insulin pump, Tandem Diabetes has purchased AMF Medical.

Handshake
• Source: Shutterstock

Tandem Diabetes Care, manufacturer of the T:slim X2 insulin pump, has purchasedAMF Medical, the Swiss developer of the Sigi Patch Pump, in a deal that could be worth up to $215m.

Expected to close in January 2023 – a rapid turnaround for an M&A deal of this size – the purchase comprises of a CHF 62

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Diabetic Care

More from Device Area